Status:
COMPLETED
Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma.
Lead Sponsor:
Austral University, Argentina
Conditions:
Medullary Thyroid Carcinoma
Nodular Goiter
Eligibility:
All Genders
18+ years
Brief Summary
Medullary thyroid carcinoma (MTC) is a tumor originating from parafollicular C cells of the thyroid. (1) Representing 1 to 7% of all thyroid carcinoma cases (2, 3, 4). It can occur in two clinical for...
Detailed Description
Investigative Question: In daily practice, what value of calcitonin in needle washing by electrochemiluminescent method allows the diagnosis and localization of medullary carcinoma in patients with t...
Eligibility Criteria
Inclusion
- Patients ≥ 18 years of age, with nodular or multinodular goiter who are undergoing surgery, with normal or elevated serum calcitonin and/or with suspected CMT due to RET mutation from 3/1/2018 to 5/31/2022 will be selected according to inclusion criteria. -
Exclusion
- Patients who do not have a remaining puncture sample, without serum calcitonin, not referred to surgery or those who are lost upon follow-up, will be excluded.
- \-
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT06067594
Start Date
March 1 2018
End Date
June 1 2022
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Austral
Pilar, Buenos Aires, Argentina, 1633